Every glowing startup profile is also a diagnostic test. The question isn't whether the company is doing good work. The question is whether a smart reader can spot the business-model hole the journalist didn't ask about. Bloomberg's piece on Claimable this week is a perfect example. The company uses AI to help patients fight denied health insurance claims. The stories are moving. The founder is a hero. The win rate is impressive. Mark Cuban is an investor. If you read it at face value, you come away thinking this is the next Turbotax for healthcare. Read it twice, and you see four problems the founders themselves are already trying to outrun. One of them is big enough to kill the company before the drugmaker pivot closes. And every one of them is the kind of problem every investor should learn to spot before they fund the next startup.